1. Home
  2. EXG vs CLDX Comparison

EXG vs CLDX Comparison

Compare EXG & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

EXG

Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$9.89

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$40.69

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXG
CLDX
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
EXG
CLDX
Price
$9.89
$40.69
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$46.60
AVG Volume (30 Days)
438.2K
948.0K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,743,000.00
Revenue This Year
N/A
$111.39
Revenue Next Year
N/A
$235.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
87.78
52 Week Low
$8.25
$21.34
52 Week High
$10.16
$45.14

Technical Indicators

Market Signals
Indicator
EXG
CLDX
Relative Strength Index (RSI) 52.06 54.46
Support Level $9.44 $28.51
Resistance Level $10.16 $45.14
Average True Range (ATR) 0.09 1.75
MACD -0.02 -0.30
Stochastic Oscillator 18.86 42.37

Price Performance

Historical Comparison
EXG
CLDX

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: